Oklo (OKLO) Q4 2024 earnings summary

Executive summary

• Achieved major commercial, technological, and regulatory milestones in 2024, including a 12 GW Master Power Agreement with Switch, a 500 MW partnership with Equinix, and began trading on the NYSE, supported by a $25 million prepayment.

• Expanded customer pipeline from 700 MW to over 14 GW, driven by surging demand from AI data centers and other sectors.

• Acquired Atomic Alchemy, entering the high-value radioisotope market with potential revenue as early as Q1 2026.

• Strategic partnerships and acquisitions, such as Atomic Alchemy, enhance the technology platform and open new revenue streams.

Financial highlights

• Full-year operating loss was $52.8 million, including $7.8 million in one-time fair market value expense and $4.7 million in non-cash stock-based compensation.

• Net loss for 2024 was $73.6 million, including $27.9 million in non-cash fair market value losses on SAFE notes and $0.6 million in tax charges, offset by $7.7 million in interest income.

• Cash used in operating activities was $38.4 million; year-end cash and marketable securities stood at $275.3 million, mainly from $276 million in business combination proceeds.

• Cash and equivalents of $97.1 million and marketable securities of $178.2 million as of year-end.

Outlook and guidance

• Cash used in operations for 2025 expected to be $65 million–$80 million, reflecting increased headcount, procurement for Idaho project, licensing fees, and Atomic Alchemy integration.

• Anticipates continued growth in customer pipeline and revenue acceleration from radioisotope sales starting in 2026.

• Regulatory fee reductions from the ADVANCE Act expected to benefit cost structure from October 2025 onward.